Header Logo

Connection

Carl Maki to Antineoplastic Agents

This is a "connection" page, showing publications Carl Maki has written about Antineoplastic Agents.
Connection Strength

0.352
  1. Novel markers of MCL1 inhibitor sensitivity in triple-negative breast cancer cells. J Biol Chem. 2024 Jun; 300(6):107375.
    View in: PubMed
    Score: 0.217
  2. The IGF-1R/AKT pathway has opposing effects on Nutlin-3a-induced apoptosis. Cancer Biol Ther. 2017 Nov 02; 18(11):895-903.
    View in: PubMed
    Score: 0.135
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.